S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
NASDAQ:SYNH

Syneos Health Stock Forecast, Price & News

$86.09
-3.90 (-4.33%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$85.54
$88.73
50-Day Range
$89.99
$102.83
52-Week Range
$69.53
$104.18
Volume
577,682 shs
Average Volume
623,817 shs
Market Capitalization
$8.93 billion
P/E Ratio
36.02
Dividend Yield
N/A
Beta
1.76
30 days | 90 days | 365 days | Advanced Chart
Receive SYNH News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.


Syneos Health logo

About Syneos Health

Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SYNH
Employees
25,000
Year Founded
N/A

Sales & Book Value

Annual Sales
$4.42 billion
Cash Flow
$4.81 per share
Book Value
$31.20 per share

Profitability

Net Income
$192.79 million
Pretax Margin
5.73%

Debt

Price-To-Earnings

Miscellaneous

Free Float
103,391,000
Market Cap
$8.93 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Today
1/19/2022
Next Earnings (Estimated)
2/17/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.32 out of 5 stars

Medical Sector

257th out of 1,414 stocks

Commercial Physical Research Industry

6th out of 27 stocks

Analyst Opinion: 2.4Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












Syneos Health (NASDAQ:SYNH) Frequently Asked Questions

Is Syneos Health a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Syneos Health stock.
View analyst ratings for Syneos Health
or view top-rated stocks.

How has Syneos Health's stock been impacted by COVID-19?

Syneos Health's stock was trading at $57.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SYNH shares have increased by 50.2% and is now trading at $86.09.
View which stocks have been most impacted by COVID-19
.

When is Syneos Health's next earnings date?

Syneos Health is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for Syneos Health
.

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) announced its earnings results on Wednesday, November, 3rd. The company reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 11.71% and a net margin of 5.04%. The business's quarterly revenue was up 22.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.93 EPS.
View Syneos Health's earnings history
.

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health issued an update on its FY 2021 earnings guidance on Wednesday, November, 10th. The company provided EPS guidance of $4.350-$4.490 for the period, compared to the Thomson Reuters consensus estimate of $4.350. The company issued revenue guidance of $5.20 billion-$5.28 billion, compared to the consensus revenue estimate of $5.25 billion.

What price target have analysts set for SYNH?

6 analysts have issued 12 month price targets for Syneos Health's stock. Their forecasts range from $90.00 to $122.00. On average, they expect Syneos Health's share price to reach $106.17 in the next twelve months. This suggests a possible upside of 23.3% from the stock's current price.
View analysts' price targets for Syneos Health
or view top-rated stocks among Wall Street analysts.

Who are Syneos Health's key executives?

Syneos Health's management team includes the following people:
  • Alistair John Macdonald, Chief Executive Officer & Director (LinkedIn Profile)
  • Jason Michael Meggs, Chief Financial Officer & Executive Vice President
  • Larry A Pickett, Chief Information & Digital Officer
  • Michelle Keefe, President-Commercial Solutions
  • Paul D. Colvin, Chief Business Officer

What is Alistair Macdonald's approval rating as Syneos Health's CEO?

322 employees have rated Syneos Health CEO Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among Syneos Health's employees.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Square (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.76%), Louisiana State Employees Retirement System (0.03%), First Hawaiian Bank (0.02%), State of Alaska Department of Revenue (0.01%), Crossmark Global Holdings Inc. (0.01%) and Fulton Bank N.A. (0.00%). Company insiders that own Syneos Health stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Paul Colvin, Robert Parks, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends for Syneos Health
.

Which major investors are selling Syneos Health stock?

SYNH stock was sold by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Crossmark Global Holdings Inc., and State of Alaska Department of Revenue. Company insiders that have sold Syneos Health company stock in the last year include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Thomas H Lee Advisors, Llc, and Tom Allen.
View insider buying and selling activity for Syneos Health
or view top insider-selling stocks.

Which major investors are buying Syneos Health stock?

SYNH stock was purchased by a variety of institutional investors in the last quarter, including First Hawaiian Bank, Courier Capital LLC, Louisiana State Employees Retirement System, and Fulton Bank N.A.. Company insiders that have bought Syneos Health stock in the last two years include Jason M Meggs, John M Dineen, and Paul Colvin.
View insider buying and selling activity for Syneos Health
or or view top insider-buying stocks.

How do I buy shares of Syneos Health?

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $86.09.

How much money does Syneos Health make?

Syneos Health has a market capitalization of $8.93 billion and generates $4.42 billion in revenue each year. The company earns $192.79 million in net income (profit) each year or $2.39 on an earnings per share basis.

How many employees does Syneos Health have?

Syneos Health employs 25,000 workers across the globe.

What is Syneos Health's official website?

The official website for Syneos Health is www.syneoshealth.com.

Where are Syneos Health's headquarters?

Syneos Health is headquartered at 1030 Sync Street, Morrisville NC, 27560.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at (919) 876-9300, via email at [email protected], or via fax at 919-876-9360.


This page was last updated on 1/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.